ストックスクリーナーアプリを入手
28.14
3.03%
-0.88
アフターアワーズ：
28.14
前日終値:
$29.02
開ける：
$28.15
24時間の取引高:
384.61K
Relative Volume:
1.03
時価総額：
$904.19M
収益：
$566.77M
当期純損益:
$48.16M
株価収益率:
23.65
EPS:
1.19
ネットキャッシュフロー:
$274.29M
1週間 パフォーマンス:
-5.28%
1か月 パフォーマンス:
+0.36%
6か月 パフォーマンス:
-32.78%
1年 パフォーマンス:
-28.40%
1日の値動き範囲:
$27.67
$28.34
1週間の範囲:
$27.67
$30.52
52週間の値動き範囲:
$27.27
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
名前
Collegium Pharmaceutical Inc
セクター
電話
781-713-3699
住所
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
28.14 | 904.19M | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
151.73 | 67.94B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 46.50B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.89 | 44.66B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.80 | 15.81B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.46 | 13.14B | 2.76B | 1.11B | 898.10M | 22.77 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | Needham | Hold → Buy |
| 2024-07-30 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | アップグレード | Jefferies | Hold → Buy |
| 2024-05-10 | ダウングレード | Needham | Buy → Hold |
| 2024-05-10 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | ダウングレード | Jefferies | Buy → Hold |
| 2023-08-25 | 繰り返されました | Needham | Buy |
| 2023-05-02 | 再開されました | Jefferies | Buy |
| 2022-08-08 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-14 | 開始されました | BWS Financial | Sell |
| 2020-05-27 | 開始されました | Guggenheim | Neutral |
| 2020-02-19 | 再開されました | Jefferies | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-03 | 再開されました | H.C. Wainwright | Buy |
| 2019-04-12 | 再開されました | Janney | Buy |
| 2019-03-20 | 開始されました | SunTrust | Hold |
| 2019-01-16 | 繰り返されました | Needham | Buy |
| 2018-03-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-02-07 | 繰り返されました | Needham | Buy |
| 2017-12-05 | 繰り返されました | Needham | Buy |
| 2017-09-11 | 開始されました | H.C. Wainwright | Buy |
| 2017-05-11 | 繰り返されました | Needham | Buy |
| 2016-09-13 | 開始されました | Gabelli & Co | Buy |
| 2015-06-01 | 開始されました | Jefferies | Buy |
| 2015-06-01 | 開始されました | Needham | Buy |
| 2015-06-01 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Collegium Pharmaceutical Inc (COLL) 最新ニュース
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average? - Yahoo Finance
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack - Yahoo Finance
Teacher Retirement System of Texas Has $274,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Exclusive: Collegium Leaders Set for Key Investor Presentation at Needham Conference - Stock Titan
Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.60 - Defense World
HighTower Advisors LLC Has $428,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Raymond James Financial Inc. Makes New Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Swiss National Bank Has $1.81 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
HC Wainwright Has Optimistic Outlook of COLL Q3 Earnings - Defense World
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting - GlobeNewswire
Q1 EPS Estimate for Collegium Pharmaceutical Cut by Analyst - Defense World
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - Yahoo Finance
Collegium Pharmaceutical (NASDAQ:COLL) Receives “Buy” Rating from HC Wainwright - Defense World
Collegium pharmaceutical CFO Colleen Tupper sells shares for $228,250 By Investing.com - Investing.com South Africa
Collegium Pharmaceutical EVP sells shares worth $624,794 - Investing.com India
Collegium Pharmaceutical EVP sells shares worth $624,794 By Investing.com - Investing.com Australia
Collegium pharmaceutical CFO Colleen Tupper sells shares for $228,250 - Investing.com India
Forecasting The Future: 4 Analyst Projections For Collegium Pharmaceutical - Benzinga
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Collegium Pharmaceutical chairman of the board to retire - MSN
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks - The Globe and Mail
Amundi Has $446,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical EVP Scott Dreyer sells $67,661 in stock By Investing.com - Investing.com Australia
Glen Santangelo Reiterates Buy Rating on Collegium Pharmaceutical, Citing Undervalued Pain Portfolio and Strong Market Positioning - TipRanks
Collegium Pharmaceutical EVP Scott Dreyer sells $67,661 in stock - Investing.com India
Collegium pharmaceutical CFO sells $29,313 in stock - Investing.com
Collegium Pharmaceutical reshuffles board, adds executives By Investing.com - Investing.com Australia
Collegium Pharmaceutical announces board changes and new EVP By Investing.com - Investing.com Canada
Collegium pharmaceutical CFO sells $29,313 in stock By Investing.com - Investing.com UK
Collegium announces updates to its board of directors, executive team - TipRanks
Collegium Announces Updates to its Board of Directors and Executive Leadership Team - citybiz
Collegium Pharmaceutical announces board changes and new EVP - Investing.com
Collegium Pharmaceutical reshuffles board, adds executives - Investing.com India
Collegium Pharmaceutical Appoints New Executive VP and General Counsel - TipRanks
Collegium Announces Updates To Its Board Of Directors And Executive Leadership Team - Marketscreener.com
Collegium's Founder Steps Down as Company Unveils Strategic Leadership Overhaul - StockTitan
Bank of New York Mellon Corp Has $7.24 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium pharmaceutical CFO sells shares worth $313,412 By Investing.com - Investing.com Australia
Collegium pharmaceutical EVP Scott Dreyer sells shares for $461,671 By Investing.com - Investing.com Australia
Collegium pharmaceutical CFO sells shares worth $313,412 - Investing.com India
Collegium pharmaceutical EVP Scott Dreyer sells shares for $461,671 - Investing.com India
Have Collegium Pharmaceutical Insiders Been Selling Stock? - Simply Wall St
Collegium pharmaceutical EVP sells shares worth $169,299 By Investing.com - Investing.com South Africa
Collegium pharmaceutical CFO sells shares worth $103,591 - Investing.com India
Collegium pharmaceutical CFO sells shares worth $103,591 By Investing.com - Investing.com Canada
Collegium Pharmaceutical Inc (COLL) 財務データ
収益
当期純利益
現金流量
EPS
5.86%
大文字化:
|
ボリューム (24 時間):